Coroner links teenage student’s death to weight-loss drug Mounjaro
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Coroner links teenage student’s death to weight-loss drug Mounjaro" is generating significant coverage in the Health category, with 3 articles from 3 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Times, The Telegraph and People.com. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 96d ago.
Quick answers
Why is "Coroner links teenage student’s death to weight-loss drug Mounjaro" trending?
Because 3 independent news sources published 3 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (3)
- Coroner links teenage student’s death to weight-loss drug Mounjaro The Times · 98d ago
- Law student died after taking fat jabs despite not being obese The Telegraph · 99d ago
- Calif. College Student, 19, Dies in U.K. Dorm Room After Taking GLP-1 Weight-Loss Drug People.com · 99d ago
Topics
Related trends
Ozempic and Mounjaro may have a surprising effect on your brain
Recent coverage examines whether popular diabetes and weight-loss drugs like Ozempic and Mounjaro influence human brain function.
Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug
A former Eli Lilly sales representative has filed a retaliation lawsuit alleging she was fired for objecting to Mounjaro marketing.
Some people are having hallucinations and other psychotic symptoms after stopping GLP-1 drugs
Two case reports describe men who developed psychosis after stopping tirzepatide, adding to questions about the psychiatric effects of discontinuing GLP-1 drugs.
GLP-1 weight-loss drugs slow biological aging, recent studies show
Recent studies indicate that popular GLP-1 weight-loss medications like Ozempic and Mounjaro may also slow biological aging.
Is long-term use of GLP-1s safe?
Medical and lifestyle experts are questioning the long-term safety and efficacy of GLP-1 medications as they transition from clinical tools to consumer drugs.
The dangerous risks of stopping Ozempic and GLP-1s
New reports warn that discontinuing GLP-1 weight-loss medications like Ozempic, Mounjaro, and Wegovy may increase the risk of heart attack and stroke.